- Home
- GRFS vs MSGS Comparison
GRFS vs MSGS Comparison
Compare GRFS & MSGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRFS
- MSGS
- Stock Information
- Founded
- GRFS 1940
- MSGS 1879
- Country
- GRFS Spain
- MSGS United States
- Employees
- GRFS N/A
- MSGS N/A
- Industry
- GRFS Biotechnology: Pharmaceutical Preparations
- MSGS Services-Misc. Amusement & Recreation
- Sector
- GRFS Health Care
- MSGS Consumer Discretionary
- Exchange
- GRFS Nasdaq
- MSGS Nasdaq
- Market Cap
- GRFS 5.1B
- MSGS 4.8B
- IPO Year
- GRFS 2006
- MSGS N/A
- Fundamental
- Price
- GRFS $7.27
- MSGS $195.07
- Analyst Decision
- GRFS
- MSGS Buy
- Analyst Count
- GRFS 0
- MSGS 1
- Target Price
- GRFS N/A
- MSGS $250.00
- AVG Volume (30 Days)
- GRFS 1.2M
- MSGS 162.5K
- Earning Date
- GRFS 07-28-2022
- MSGS 05-01-2025
- Dividend Yield
- GRFS N/A
- MSGS N/A
- EPS Growth
- GRFS 283.33
- MSGS 47.09
- EPS
- GRFS 0.24
- MSGS 2.36
- Revenue
- GRFS $7,467,006,939.00
- MSGS $1,068,271,000.00
- Revenue This Year
- GRFS $8.45
- MSGS N/A
- Revenue Next Year
- GRFS $7.08
- MSGS $6.72
- P/E Ratio
- GRFS $35.68
- MSGS $82.77
- Revenue Growth
- GRFS 9.41
- MSGS 21.45
- 52 Week Low
- GRFS $5.79
- MSGS $178.35
- 52 Week High
- GRFS $9.96
- MSGS $237.99
- Technical
- Relative Strength Index (RSI)
- GRFS 37.73
- MSGS 43.24
- Support Level
- GRFS $7.13
- MSGS $195.27
- Resistance Level
- GRFS $7.81
- MSGS $199.99
- Average True Range (ATR)
- GRFS 0.24
- MSGS 4.22
- MACD
- GRFS -0.11
- MSGS 1.23
- Stochastic Oscillator
- GRFS 13.33
- MSGS 59.84
About GRFS Grifols S.A.
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.
About MSGS Madison Square Garden Sports Corp. (New)
Madison Square Garden Sports Corp owns and operates a portfolio of assets featuring some of the recognized sports teams, including the Knicks of the NBA and the Rangers of the NHL. It generates revenue from several sources: ticket sales and a portion of suite rental fees at The Garden and others. It has one operating and reportable segment and one reporting unit for goodwill impairment testing purposes.